Cargando…
Are we ready to combat the ecotoxicity of COVID-19 pharmaceuticals? An in silico aquatic risk assessment
To fight COVID-19 with uncountable medications and bioproducts throughout the world has taken us to another challenge of ecotoxicity. The indiscriminate usage followed by improper disposal of unused antibacterials, antivirals, antimalarials, immunomodulators, angiotensin II receptor blockers, cortic...
Autores principales: | Khan, Kabiruddin, Kar, Supratik, Roy, Kunal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898056/ https://www.ncbi.nlm.nih.gov/pubmed/36758333 http://dx.doi.org/10.1016/j.aquatox.2023.106416 |
Ejemplares similares
-
In Silico Models for Ecotoxicity of Pharmaceuticals
por: Roy, Kunal, et al.
Publicado: (2016) -
Impact of Pharmaceuticals on the Environment: Risk Assessment Using QSAR Modeling Approach
por: Kar, Supratik, et al.
Publicado: (2018) -
Solubility Constraints on Aquatic Ecotoxicity Testing of Anionic Surfactants
por: Hammer, J., et al.
Publicado: (2018) -
Aquatic Ecotoxicity Testing of Nanoparticles—The Quest To Disclose Nanoparticle Effects
por: Skjolding, Lars Michael, et al.
Publicado: (2016) -
Metoprolol and Its Degradation and Transformation Products Using AOPs—Assessment of Aquatic Ecotoxicity Using QSAR
por: Voigt, Melanie, et al.
Publicado: (2021)